Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

MLA

Angeli, P., et al. “Reversal of Type 1 Hepatorenal Syndrome with the Administration of Midodrine and Octreotide.” Hepatology (Baltimore, Md.), vol. 29, no. 6, June 1999, pp. 1690–97. EBSCOhost, https://doi.org/10.1002/hep.510290629.

APA

Angeli, P., Volpin, R., Gerunda, G., Craighero, R., Roner, P., Merenda, R., Amodio, P., Sticca, A., Caregaro, L., Maffei-Faccioli, A., & Gatta, A. (1999). Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (Baltimore, Md.), 29(6), 1690–1697. https://doi.org/10.1002/hep.510290629

Chicago

Angeli, P, R Volpin, G Gerunda, R Craighero, P Roner, R Merenda, P Amodio, et al. 1999. “Reversal of Type 1 Hepatorenal Syndrome with the Administration of Midodrine and Octreotide.” Hepatology (Baltimore, Md.) 29 (6): 1690–97. doi:10.1002/hep.510290629.